PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Tinzaparin sodium - VTE prevention post hip/knee replacement

PAD Profile : Tinzaparin sodium - VTE prevention post hip/knee replacement

Keywords :
VTE prophylaxis, venous thromboembolism, Low molecular weight heparins, LMWH, SWLEOC guidelines
Brand Names Include :
Innohep

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date

Committee Recommendations

Date
Committee Name
Narrative
27 October 2010
Not Set
The use of LMWH to prevent VTE post operatively is considered as red on the traffic light system. The full course of treatment should be supplied by the Acute Trust.

Associated BNF Codes

02. Cardiovascular System
02.08.01. Parenteral anticoagulants
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More